Nanoparticle Transport Across the Blood Brain Barrier Increases with Alzheimer's and Age, Study Finds
https://reachmd.com/news/nanoparticle-transport-across-the-blood-brain-barrier-increases-with-alzheimers-and-age-study-finds/2456761/
Graphical abstract. Credit: Nano Letters (2023). DOI: 10.1021/acs.nanolett.3c03222 Neurodegenerative disorders such as Alzheimer's disease affect more than 270 million people worldwide. AD is the leading cause of dementia, resulting in memory loss due to atrophy of neurons in the hippocampu…
A Type of Allergy Medicine Might Help Treat Lung Cancer
https://reachmd.com/news/a-type-of-allergy-medicine-might-help-treat-lung-cancer/2456740/
Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC). And in an early parallel study in humans, combining immunotherapy with dupilumab -- an Interleukin…
Mirvetuximab Soravtansine-Gynx Approved for Ovarian Cancer
https://reachmd.com/news/mirvetuximab-soravtansine-gynx-approved-for-ovarian-cancer/2467126/
April 24, 2024, by Linda Wang Antibody–drug conjugates include an antibody (yellow) attached to a cytotoxic drug (red spiky ball). When the antibody finds its target…
Newly Discovered Genetic Malfunction Causes Rare Lung Disease
https://reachmd.com/news/newly-discovered-genetic-malfunction-causes-rare-lung-disease/2457095/
Rather than battle bacterial infection or reduce sticky buildup in the lungs, these alveolar macrophages (pink) taken from the lungs of a sick child wander aimlessly, the result of a newly discovered genetic deficiency. (Anna-Lena Neehus) The macrophage is one of the body’s most important in…
Genetic Discovery Reveals Who Can Benefit from Preterm Birth Therapy
https://reachmd.com/news/genetic-discovery-reveals-who-can-benefit-from-preterm-birth-therapy/2463163/
A UC San Francisco-led study has for the first time identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth, a condition that affects 1 in 10 infants born in the United States. The findings are critical because no medication is available in the…
FAU Researchers Land $1M in FDOH Grants to Fight Alzheimer’s Disease
https://reachmd.com/news/fau-researchers-land-1m-in-fdoh-grants-to-fight-alzheimers-disease/2462983/
Three Florida Atlantic University researchers at the forefront of Alzheimer’s disease (AD) research have each received a $350,000 grant from the Florida Department of Health’s “Ed and Ethel Moore Alzheimer’s Disease Research Program.” The Ed and Ethel Moore Alzheimer’s Disease Research Program …
Evading Bacterial Resistance: Scientists Develop Groundbreaking New Antibiotic
https://reachmd.com/news/evading-bacterial-resistance-scientists-develop-groundbreaking-new-antibiotic/2457274/
Scientists from the University of Illinois Chicago and Harvard University have developed a new antibiotic, cresomycin, as a potential tool against drug-resistant bacteria. This achievement stems from research into how antibiotics interact with the bacterial ribosome and strategies to overcome bacte…
Novel Lipopeptide Proves Lethal Against Staphylococcus Aureus
https://reachmd.com/news/novel-lipopeptide-proves-lethal-against-staphylococcus-aureus/2466964/
A scanning electron microscopy image of Staphylococcus aureus after treatment with 25 mg/mL of serrawettin W2-FL10 for one hour. A magnification (500 nm) of damaged S. aureus cells is indicated in the red block. Credit: Tanya Dec…
Anemia May Contribute to Higher Female Mortality During Heart Surgery
https://reachmd.com/news/anemia-may-contribute-to-higher-female-mortality-during-heart-surgery/2462713/
Women are at higher risk of death when undergoing heart bypass surgery than men. Researchers at Weill Cornell Medicine have determined that this disparity is mediated, to a large extent, by intraoperative anemia—the loss of red blood cells during surgery. The study, published on March 5,…
FDA Approves Second-Line Tislelizumab Monotherapy in Esophageal Cancer
https://reachmd.com/news/fda-approves-second-line-tislelizumab-monotherapy-in-esophageal-cancer/2462506/
Data from the phase 3 RATIONALE 302 trial (NCT03430843) supported the FDA approval of tislelizumab-jsgr as a treatment for those with previously treated unresectable or metastatic esophageal squamous cell carcinoma.The FDA has approved tislelizumab-jsgr (Tevimbra) monotherapy for patients with unre…